IL128782A0 - Crystalline pharmaceutical product - Google Patents

Crystalline pharmaceutical product

Info

Publication number
IL128782A0
IL128782A0 IL12878297A IL12878297A IL128782A0 IL 128782 A0 IL128782 A0 IL 128782A0 IL 12878297 A IL12878297 A IL 12878297A IL 12878297 A IL12878297 A IL 12878297A IL 128782 A0 IL128782 A0 IL 128782A0
Authority
IL
Israel
Prior art keywords
pharmaceutical product
crystalline pharmaceutical
crystalline
product
pharmaceutical
Prior art date
Application number
IL12878297A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL128782A0 publication Critical patent/IL128782A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12878297A 1996-09-03 1997-08-29 Crystalline pharmaceutical product IL128782A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2536996P 1996-09-03 1996-09-03
PCT/US1997/015292 WO1998009629A1 (en) 1996-09-03 1997-08-29 Crystalline pharmaceutical product

Publications (1)

Publication Number Publication Date
IL128782A0 true IL128782A0 (en) 2000-01-31

Family

ID=21825633

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12878297A IL128782A0 (en) 1996-09-03 1997-08-29 Crystalline pharmaceutical product

Country Status (32)

Country Link
US (1) US6335330B1 (es)
EP (1) EP0964684B1 (es)
JP (1) JP2000517342A (es)
CN (1) CN1102391C (es)
AP (1) AP9901472A0 (es)
AR (1) AR008154A1 (es)
AT (1) ATE245984T1 (es)
AU (1) AU731173B2 (es)
BG (1) BG103196A (es)
BR (1) BR9711981A (es)
CA (1) CA2264607A1 (es)
CO (1) CO4930262A1 (es)
CZ (1) CZ71999A3 (es)
DE (1) DE69723873T2 (es)
DZ (1) DZ2302A1 (es)
EA (1) EA001363B1 (es)
ES (1) ES2205254T3 (es)
HU (1) HUP9904077A3 (es)
ID (1) ID18156A (es)
IL (1) IL128782A0 (es)
MA (1) MA24309A1 (es)
MY (1) MY118175A (es)
NO (1) NO991013D0 (es)
NZ (1) NZ334438A (es)
OA (1) OA10986A (es)
PE (1) PE107198A1 (es)
PL (1) PL332006A1 (es)
SK (1) SK27699A3 (es)
TR (1) TR199900480T2 (es)
UY (1) UY24690A1 (es)
WO (1) WO1998009629A1 (es)
ZA (1) ZA977870B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19902529A1 (de) * 1999-01-22 2000-08-03 Goldwell Gmbh Haarbehandlungsmittel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
CN100560131C (zh) 2001-10-22 2009-11-18 斯克里普斯研究学院 抗体靶向化合物
US20050202151A1 (en) * 2004-03-15 2005-09-15 Land O'lakes, Inc. Method of preparing egg nuggets
KR101046977B1 (ko) * 2004-11-15 2011-07-07 삼성에스디아이 주식회사 카본나노튜브, 이를 포함한 전자 방출원 및 이를 구비한전자 방출 소자
US20070122408A1 (en) * 2005-10-20 2007-05-31 The Scripps Research Institute Fc Labeling for Immunostaining and Immunotargeting
US8518927B2 (en) 2009-02-10 2013-08-27 The Scripps Research Institute Chemically programmed vaccination

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD138319A1 (de) * 1978-08-08 1979-10-24 Helmut Roehnert Verfahren zur herstellung einer stabilen,kristallwasser-und kristalloesungsmittelfreien kristallform des 7-chlor-2-methylamino-5-phenyl-3h-1,4-benzodiazepin-4-oxid-hydrochlorids
ES2190428T3 (es) 1991-06-28 2003-08-01 Smithkline Beecham Corp Antagonistas biciclicos de fibrinogeno.
US5939412A (en) 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
DE69332860T2 (de) 1992-12-21 2004-03-11 Smithkline Beecham Corp. Bicyklische fibrinogen antagoniste
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.

Also Published As

Publication number Publication date
NO991013L (no) 1999-03-02
AR008154A1 (es) 1999-12-09
EP0964684A1 (en) 1999-12-22
PL332006A1 (en) 1999-08-16
TR199900480T2 (xx) 1999-06-21
CN1102391C (zh) 2003-03-05
EP0964684B1 (en) 2003-07-30
DE69723873T2 (de) 2004-04-22
MY118175A (en) 2004-09-30
EP0964684A4 (en) 2002-05-29
HUP9904077A3 (en) 2002-03-28
AU4242597A (en) 1998-03-26
EA001363B1 (ru) 2001-02-26
JP2000517342A (ja) 2000-12-26
WO1998009629A1 (en) 1998-03-12
EA199900260A1 (ru) 1999-08-26
US6335330B1 (en) 2002-01-01
CN1234739A (zh) 1999-11-10
DZ2302A1 (fr) 2002-12-28
CO4930262A1 (es) 2000-06-27
AP9901472A0 (en) 1999-03-31
CA2264607A1 (en) 1998-03-12
BG103196A (en) 1999-09-30
ES2205254T3 (es) 2004-05-01
BR9711981A (pt) 1999-08-24
NZ334438A (en) 2000-10-27
OA10986A (en) 2003-03-04
HUP9904077A2 (hu) 2000-05-28
ID18156A (id) 1998-03-05
NO991013D0 (no) 1999-03-02
SK27699A3 (en) 2000-02-14
CZ71999A3 (cs) 1999-08-11
ATE245984T1 (de) 2003-08-15
ZA977870B (en) 1998-03-03
DE69723873D1 (de) 2003-09-04
PE107198A1 (es) 1999-03-21
MA24309A1 (fr) 1998-04-01
UY24690A1 (es) 1998-02-27
AU731173B2 (en) 2001-03-22

Similar Documents

Publication Publication Date Title
EG23763A (en) Novel pharmaceutical product
GB9602080D0 (en) Pharmaceutical compounds
ZA96527B (en) Novel pharmaceutical combination
GB9610862D0 (en) Pharmaceutical products
ZA957753B (en) Novel pharmaceutical product
GB9801538D0 (en) Pharmaceutical product
GB9609976D0 (en) Pharmaceutical compounds
GB9621789D0 (en) Pharmaceutical compounds
GB9505524D0 (en) Product
HUP9904077A3 (en) Crystalline pharmaceutical product
EP0923564A4 (en) PHARMACEUTICAL COMPOUNDS
GB9619894D0 (en) Pharmaceutical products
ZA979329B (en) Pharmaceutical compounds
GB9626151D0 (en) Pharmaceutical compounds
GB9514252D0 (en) Mouldable product
AU126984S (en) Pharmaceutical product
GB9513762D0 (en) Product
GB9612684D0 (en) Pharmaceutical products
GB9413859D0 (en) Pharmaceutical products
GB9620834D0 (en) Pharmaceutical products
GB9620465D0 (en) Pharmaceutical products
SG32504A1 (en) Novel pharmaceutical product
ZA968431B (en) Pharmaceutical product
GB9624891D0 (en) Product
GB9624919D0 (en) Product